POLY MEDICURE LTD.

Company Profile

POLY MEDICURE LTD. had its IPO on under the ticker symbol POLYMED.

The company operates in the sector and industry. POLY MEDICURE LTD. has a staff strength of 0 employees.

Stock update

Shares of POLY MEDICURE LTD. opened at ₹1358.6 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹1333 - ₹1404.9, and closed at ₹1339.9.

This is a -2.93% slip from the previous day's closing price.

A total volume of 10,343 shares were traded at the close of the day’s session.

In the last one week, shares of POLY MEDICURE LTD. have slipped by -4.08%.

POLY MEDICURE LTD.'s Key Ratios

POLY MEDICURE LTD. has a market cap of ₹86.46 billion, indicating a price to book ratio of 7.7327 and a price to sales ratio of 8.734.

In the last 12-months POLY MEDICURE LTD.’s revenue was ₹0 with a gross profit of ₹4.68 billion and an EBITDA of ₹0. The EBITDA ratio measures POLY MEDICURE LTD.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, POLY MEDICURE LTD.’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q1, POLY MEDICURE LTD.’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

POLY MEDICURE LTD.’s PE and PEG Ratio

Forward PE

0

Trailing PE

84.113

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into POLY MEDICURE LTD.’s profitability.

POLY MEDICURE LTD. stock is trading at a EV to sales ratio of 8.5256 and a EV to EBITDA ratio of 34.5616. Its price to sales ratio in the trailing 12-months stood at 8.734.

POLY MEDICURE LTD. stock pays annual dividends of ₹2 per share, indicating a yield of 0.2% and a payout ratio of 19.93%.

Balance sheet and cash flow metrics

Total Assets

₹15.77 billion

Total Liabilities

₹2.93 billion

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

19.93%

POLY MEDICURE LTD. ended 2024 with ₹15.77 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹15.77 billion while shareholder equity stood at ₹12.42 billion.

POLY MEDICURE LTD. ended 2024 with ₹0 in deferred long-term liabilities, ₹2.93 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹285.81 million in goodwill. Its cash balance stood at ₹70.62 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹175.01 million.

POLY MEDICURE LTD.’s total current assets stands at ₹8.07 billion while long-term investments were ₹0 and short-term investments were ₹3.02 billion. Its net receivables were ₹2.35 billion compared to accounts payable of ₹923.15 million and inventory worth ₹2.09 billion.

In 2024, POLY MEDICURE LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, POLY MEDICURE LTD. paid ₹0.20 in dividends in 2024.

Other key metrics

Current Trading Price

₹1339.9

52-Week High

₹1044.4

52-Week Low

₹650.5083

Analyst Target Price

₹

POLY MEDICURE LTD. stock is currently trading at ₹1339.9 per share. It touched a 52-week high of ₹1044.4 and a 52-week low of ₹1044.4. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹1292.11 and 200-day moving average was ₹1038.76 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.